Annual Current Liabilities
$19.13 M
+$45.00 K+0.24%
December 31, 2023
Summary
- As of February 25, 2025, AKRO annual total current liabilities is $19.13 million, with the most recent change of +$45.00 thousand (+0.24%) on December 31, 2023.
- During the last 3 years, AKRO annual current liabilities has risen by +$6.02 million (+45.89%).
- AKRO annual current liabilities is now -23.88% below its all-time high of $25.13 million, reached on December 31, 2021.
Performance
AKRO Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$43.29 M
+$12.12 M+38.87%
September 30, 2024
Summary
- As of February 25, 2025, AKRO quarterly total current liabilities is $43.29 million, with the most recent change of +$12.12 million (+38.87%) on September 30, 2024.
- Over the past year, AKRO quarterly current liabilities has increased by +$14.84 million (+52.18%).
- AKRO quarterly current liabilities is now at all-time high.
Performance
AKRO Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
AKRO Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.2% | +52.2% |
| 3 y3 years | +45.9% | +83.9% |
| 5 y5 years | +716.7% | +543.7% |
AKRO Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -23.9% | +0.2% | at high | +159.6% |
| 5 y | 5-year | -23.9% | +104.2% | at high | +422.5% |
| alltime | all time | -23.9% | +8516.2% | at high | +1748.5% |
Akero Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $43.29 M(+38.9%) |
| Jun 2024 | - | $31.17 M(+3.0%) |
| Mar 2024 | - | $30.26 M(+58.2%) |
| Dec 2023 | $19.13 M(+0.2%) | $19.13 M(-32.8%) |
| Sep 2023 | - | $28.45 M(+31.7%) |
| Jun 2023 | - | $21.60 M(+29.5%) |
| Mar 2023 | - | $16.68 M(-12.6%) |
| Dec 2022 | $19.08 M(-24.1%) | $19.08 M(-24.4%) |
| Sep 2022 | - | $25.24 M(-5.4%) |
| Jun 2022 | - | $26.70 M(+20.8%) |
| Mar 2022 | - | $22.10 M(-12.1%) |
| Dec 2021 | $25.13 M | $25.13 M(+6.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $23.54 M(+43.0%) |
| Jun 2021 | - | $16.46 M(+62.4%) |
| Mar 2021 | - | $10.14 M(-22.7%) |
| Dec 2020 | $13.11 M(+39.9%) | $13.11 M(+9.1%) |
| Sep 2020 | - | $12.01 M(+15.6%) |
| Jun 2020 | - | $10.39 M(+25.4%) |
| Mar 2020 | - | $8.29 M(-11.6%) |
| Dec 2019 | $9.37 M(+300.0%) | $9.37 M(+39.3%) |
| Sep 2019 | - | $6.72 M(+41.9%) |
| Jun 2019 | - | $4.74 M(+97.2%) |
| Mar 2019 | - | $2.40 M(+2.6%) |
| Dec 2018 | $2.34 M(+955.0%) | $2.34 M |
| Dec 2017 | $222.00 K | - |
FAQ
- What is Akero Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Akero Therapeutics?
- What is Akero Therapeutics annual current liabilities year-on-year change?
- What is Akero Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Akero Therapeutics?
- What is Akero Therapeutics quarterly current liabilities year-on-year change?
What is Akero Therapeutics annual total current liabilities?
The current annual current liabilities of AKRO is $19.13 M
What is the all time high annual current liabilities for Akero Therapeutics?
Akero Therapeutics all-time high annual total current liabilities is $25.13 M
What is Akero Therapeutics annual current liabilities year-on-year change?
Over the past year, AKRO annual total current liabilities has changed by +$45.00 K (+0.24%)
What is Akero Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of AKRO is $43.29 M
What is the all time high quarterly current liabilities for Akero Therapeutics?
Akero Therapeutics all-time high quarterly total current liabilities is $43.29 M
What is Akero Therapeutics quarterly current liabilities year-on-year change?
Over the past year, AKRO quarterly total current liabilities has changed by +$14.84 M (+52.18%)